Brusatol enhances MEF2A expression to inhibit RCC progression through the Wnt signalling pathway in renal cell

Tao Wang1, Yu Zhou1, Hui Bao1

  • 1Department of Urology, General Hospital of the Central Theater Command, Wuhan, China.

Insights

Myocyte enhancer factor 2A (MEF2A) overexpression inhibits renal cell carcinoma (RCC) progression. This study reveals MEF2A

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Renal cell carcinoma (RCC) is an aggressive kidney tumor with increasing incidence and poor prognosis.
  • Brusatol, derived from Brucea javanica, shows potent antitumour properties.
  • Identifying novel therapeutic targets for RCC is crucial.

Purpose of the Study:

  • To investigate the role of Myocyte Enhancer Factor 2A (MEF2A) in renal cell carcinoma (RCC).
  • To explore brusatol's protective effects on MEF2A in RCC.
  • To elucidate the underlying molecular mechanisms of MEF2A in inhibiting RCC progression.

Main Methods:

  • Bioinformatic analysis to identify brusatol targets, selecting MEF2A.
  • In vitro assays (RT-PCR, Western blot, CCK8, colony formation, immunofluorescence, wound healing, flow cytometry, Transwell) and in vivo xenograft mouse models.
  • Investigation of MEF2A expression, deubiquitylation, and its impact on Wnt/β-catenin signaling.

Main Results:

  • MEF2A expression is reduced in RCC patients and correlates with deubiquitylation.
  • Brusatol demonstrated protective effects on MEF2A.
  • MEF2A overexpression inhibited RCC cell proliferation, invasion, migration, and epithelial-mesenchymal transition (EMT), reducing tumor size in mice via Wnt/β-catenin signaling modulation.

Conclusions:

  • MEF2A functions as a tumor suppressor in RCC.
  • MEF2A overexpression inhibits RCC progression through the Wnt/β-catenin signaling pathway.
  • MEF2A represents a potential diagnostic marker and therapeutic target for RCC.

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.5K